Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7AP14 is a processed pseudogene related to the ribosomal protein L7a. Pseudogenes are DNA segments that resemble functional genes but have lost their protein-coding ability or are otherwise non-functional due to mutations or deletions[2][5][6][8][10]. RPL7AP14 is located on chromosome 20 (20q11.23). Unlike its functional paralog RPL7A, which encodes a protein component of the 60S ribosomal subunit, RPL7AP14 does not produce a protein and has no characterized biological function, disease associations, or drug interactions[2][8][10]. This entry is a pseudogene — not a protein-coding gene, receptor, enzyme, or known therapeutic target. It should not be considered a molecular target for pharmacology or drug development[2][6][8][10]. The presence of many aliases is typical for pseudogenes, reflecting their similarity to functional genes. If information for drug-target interactions, functional role, or biomarker status is required, the query should refer to a functional gene such as RPL7A instead[3][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 14 (RPL7AP14).